0001225208-23-006012.txt : 20230517
0001225208-23-006012.hdr.sgml : 20230517
20230517163037
ACCESSION NUMBER: 0001225208-23-006012
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230516
FILED AS OF DATE: 20230517
DATE AS OF CHANGE: 20230517
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fitzgerald Joseph Michael
CENTRAL INDEX KEY: 0001484186
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11083
FILM NUMBER: 23932187
MAIL ADDRESS:
STREET 1: C/O BOSTON SCIENTIFIC
STREET 2: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP
CENTRAL INDEX KEY: 0000885725
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042695240
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
BUSINESS PHONE: 508-683-4000
MAIL ADDRESS:
STREET 1: 300 BOSTON SCIENTIFIC WAY
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752-1234
4
1
doc4.xml
X0407
4
2023-05-16
0000885725
BOSTON SCIENTIFIC CORP
BSX
0001484186
Fitzgerald Joseph Michael
300 BOSTON SCIENTIFIC WAY
MARLBOROUGH
MA
01752-1234
1
EVP & Group Pres, Cardiology
0
Common Stock
2023-05-16
4
M
0
56921.0000
13.0800
A
277198.0000
D
Common Stock
2023-05-16
4
S
0
63339.0000
53.5982
D
213859.0000
D
Common Stock
68044.0000
I
By 401(k)
Common Stock
4344.0000
I
By Child
Stock Option (Right to Buy)
13.0800
2023-05-16
4
M
0
56921.0000
0.0000
D
2024-02-24
Common Stock
56921.0000
0.0000
D
The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on February 15, 2023, intended to comply with the prior version of Rule 10b5-1(c).
Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $53.37 to $53.80, inclusive. The reporting person undertakes to provide upon request by the U.S.Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
The reporting person disclaims beneficial ownership of the shares held by his child, and this report should not be deemed an admission that the reporting person is the beneficial owner of his child's shares for purposes of Section 16 or for any other purpose.
Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.
/s/ Susan Thompson, Attorney-in-Fact
2023-05-17